Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3

Interventions

Metformin 91Clomiphene 31Letrozole 23Inositol 19Folic Acid 11Chorionic Gonadotropin 11Exercise 10High-Intensity Interval Training 9drospirenone and ethinyl estradiol combination 8Ethinyl Estradiol 8Contraceptives, Oral 8Cholecalciferol 8cetrorelix 7Tablets 7Progesterone 7Menotropins 6follitropin alfa 5Pioglitazone 5Liraglutide 5Exenatide 5Cyproterone Acetate 5Caloric Restriction 5Vitamin D 4Triptorelin Pamoate 4Surveys and Questionnaires 4Sugars 4Spironolactone 4Glycoprotein Hormones, alpha Subunit 4Fish Oils 4Estradiol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Polycystic Ovary Syndrome × Ovidrel × Clear all
NCT00747617 2018-11-21

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

University of California, San Diego

Phase 3 Completed
25 enrolled 7 charts

Polycystic Ovary Syndrome

NCT00989781 2018-06-04

Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

University of California, San Diego

Phase NA Completed
41 enrolled 8 charts

Polycystic Ovary Syndrome

NCT03440359 2018-02-26

Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

Eastern Virginia Medical School

Phase 2/3 Completed
52 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡